» Articles » PMID: 33565009

Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo

Overview
Publisher Springer
Specialty Pharmacology
Date 2021 Feb 10
PMID 33565009
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Encapsulating genetic material into biocompatible polymeric microparticles is a means to improving gene transfection while simultaneously decreasing the tendency for inflammatory responses; and can be advantageous in terms of delivering material directly to the lungs via aerosolization for applications such as vaccinations. In this study, we investigated the advantages of using polymeric microparticles carrying the luciferase reporter gene in increasing transfection efficiency in the readily transfectable HEK293 cell line and the difficult to transfect RAW264.7 cell line. The results indicated that there was a limit to the ratio of nitrogen in polyethylenimine (PEI) to phosphate in DNA (N/P ratio) beyond which further increases in transgene expression no longer, or only marginally, occurred. Microparticles encapsulating PEI:DNA nanoplexes induced cellular toxicity in a dose-dependent manner. PEGylation increased transgene expression, likely related to enhanced degradation of particles. Furthermore, intra-tracheal instillation in rats allowed us to investigate the inflammatory response in the lung as a function of PEGylation, porosity, and size. Porosity did not influence cell counts in bronchoalveolar lavage fluid in the absence of PEG, but in particles containing PEG, non-porous particles recruited fewer inflammatory cells than their porous counterparts. Finally, both 1 μm and 10 μm porous PLA-PEG particles recruited more neutrophils than 4 μm particles. Thus, we have shown that PEGylation and lack of porosity are advantageous for faster release of genetic cargo from microparticles and a reduced inflammatory response, respectively.

Citing Articles

Tuning the Emulsion Properties Influences the Size of Poly(Caprolactone) Particles for Drug Delivery Applications.

Manning A, Rowlands C, Saindon H, Givens B AAPS J. 2023; 25(6):100.

PMID: 37891411 DOI: 10.1208/s12248-023-00869-4.

References
1.
Ahmed K, Geary S, Salem A . Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines. J Control Release. 2017; 248:1-9. PMC: 5309920. DOI: 10.1016/j.jconrel.2016.12.036. View

2.
Frohlich E . The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine. 2012; 7:5577-91. PMC: 3493258. DOI: 10.2147/IJN.S36111. View

3.
Vila A, Gill H, McCallion O, Alonso M . Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release. 2004; 98(2):231-44. DOI: 10.1016/j.jconrel.2004.04.026. View

4.
Bryan J . Developing an HPV vaccine to prevent cervical cancer and genital warts. Vaccine. 2007; 25(16):3001-6. DOI: 10.1016/j.vaccine.2007.01.013. View

5.
Rosales C . Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?. Front Physiol. 2018; 9:113. PMC: 5826082. DOI: 10.3389/fphys.2018.00113. View